These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 749812

  • 1. Evaluation of immunological parameters in rabbits inoculated with Staphylococcus aureus in view of specific and non-specific stimulation.
    Giedrys-Galant S, Podkowińska I, Hałasa J, Bohatyrewicz R, Daszko J.
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):583-7. PubMed ID: 749812
    [Abstract] [Full Text] [Related]

  • 2. Composition and evaluation of the efficacy of Staphylococcus aureus vaccine.
    Cameron CM, Fuls WJ, Botha WF.
    Onderstepoort J Vet Res; 1979 Mar; 46(1):1-8. PubMed ID: 460818
    [Abstract] [Full Text] [Related]

  • 3. Experimental trial in heifers vaccinated with Staphylococcus aureus avirulent mutant against bovine mastitis.
    Pellegrino M, Giraudo J, Raspanti C, Nagel R, Odierno L, Primo V, Bogni C.
    Vet Microbiol; 2008 Feb 05; 127(1-2):186-90. PubMed ID: 17869031
    [Abstract] [Full Text] [Related]

  • 4. Is there a future for a Staphylococcus aureus vaccine?
    Proctor RA.
    Vaccine; 2012 Apr 19; 30(19):2921-7. PubMed ID: 22115633
    [Abstract] [Full Text] [Related]

  • 5. Lack of protection of mice against Staphylococcus aureus despite a significant immune response to immunization with a DNA vaccine encoding collagen-binding protein.
    Therrien R, Lacasse P, Grondin G, Talbot BG.
    Vaccine; 2007 Jun 28; 25(27):5053-61. PubMed ID: 17532546
    [Abstract] [Full Text] [Related]

  • 6. Immune responses to a Staphylococcus aureus GapC/B chimera and its potential use as a component of a vaccine for S. aureus mastitis.
    Perez-Casal J, Prysliak T, Kerro-Dego O, Potter AA.
    Vet Immunol Immunopathol; 2006 Jan 15; 109(1-2):85-97. PubMed ID: 16165220
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the humoral immune response in BALB/c mice immunized with a naked DNA vaccine anti-methicillin-resistant Staphylococcus aureus.
    Roth DM, Senna JP, Machado DC.
    Genet Mol Res; 2006 Aug 31; 5(3):503-12. PubMed ID: 17117366
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Humoral response to Staphylococcus aureus antigens evaluated by the western blotting method].
    Tyski S, Jarecka K, Gut W, Hryniewicz W.
    Med Dosw Mikrobiol; 1991 Aug 31; 43(1-2):11-7. PubMed ID: 1784133
    [Abstract] [Full Text] [Related]

  • 10. [Contribution to the study of the factors of pathogenicity of staphylococci in relation to specific immunity. II. Morpho-lesional aspects obtained in specifically immunized rabbits infected with homologous and heterologous strains of pathogenic staphylococci intradermally injected].
    Nestoresco N, Popovici M, Alexenco E, Trifu P.
    Arch Roum Pathol Exp Microbiol; 1964 Dec 31; 23(4):899-910. PubMed ID: 5836095
    [No Abstract] [Full Text] [Related]

  • 11. Evaluation of certain immunological parameters in the course of autovaccine treatment in patients with chronic ostitis and carbunculosis.
    Hałasa J, Giedrys-Galant S, Podkowińska I, Braun J, Strzelecka G, Dabrowski W.
    Arch Immunol Ther Exp (Warsz); 1978 Dec 31; 26(1-6):589-93. PubMed ID: 749813
    [Abstract] [Full Text] [Related]

  • 12. Challenges for a universal Staphylococcus aureus vaccine.
    Proctor RA.
    Clin Infect Dis; 2012 Apr 31; 54(8):1179-86. PubMed ID: 22354924
    [Abstract] [Full Text] [Related]

  • 13. Bactericidal capacity of plasma and granulocytes in small-for-dates newborns.
    Prokopowicz J, Ziobro J, Iwaszko-Krawczuk W.
    Acta Paediatr Acad Sci Hung; 1975 Apr 31; 16(3-4):267-70. PubMed ID: 1224974
    [Abstract] [Full Text] [Related]

  • 14. [Immunogenicity and antigenic properties of staphylococcal toxoid and vaccine in laboratory animals. II. Staphylococcal vaccine].
    Wysokińska T, Albrycht H.
    Med Dosw Mikrobiol; 1973 Apr 31; 25(3):205-11. PubMed ID: 4760223
    [No Abstract] [Full Text] [Related]

  • 15. A vaccine to prevent infections with Staphylococcus aureus.
    Thiemermann C.
    Med Sci Monit; 2002 Sep 31; 8(9):LE35-6. PubMed ID: 12365409
    [No Abstract] [Full Text] [Related]

  • 16. Strategies for and advances in the development of Staphylococcus aureus prophylactic vaccines.
    Broughan J, Anderson R, Anderson AS.
    Expert Rev Vaccines; 2011 May 31; 10(5):695-708. PubMed ID: 21604989
    [Abstract] [Full Text] [Related]

  • 17. Induction of Staphylococcus aureus-specific IgA and agglutination potency in milk of cows by mucosal immunization.
    Tempelmans Plat-Sinnige MJ, Verkaik NJ, van Wamel WJ, de Groot N, Acton DS, van Belkum A.
    Vaccine; 2009 Jun 19; 27(30):4001-9. PubMed ID: 19389449
    [Abstract] [Full Text] [Related]

  • 18. Staphylococcus aureus antigens and challenges in vaccine development.
    Middleton JR.
    Expert Rev Vaccines; 2008 Aug 19; 7(6):805-15. PubMed ID: 18665778
    [Abstract] [Full Text] [Related]

  • 19. Master mechanisms of Staphylococcus aureus: consider its excellent protective mechanisms hindering vaccine development!
    Zhang X, Marichannegowda MH, Rakesh KP, Qin HL.
    Microbiol Res; 2018 Aug 19; 212-213():59-66. PubMed ID: 29853168
    [Abstract] [Full Text] [Related]

  • 20. Towards the immune proteome of Staphylococcus aureus - The anti-S. aureus antibody response.
    Holtfreter S, Kolata J, Bröker BM.
    Int J Med Microbiol; 2010 Feb 19; 300(2-3):176-92. PubMed ID: 19889576
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.